PDO

Early Growth Response Gene 1 (Egr1) Fish Probe Kit For Specimen Characterization

Product code
PDO
Device name
Early Growth Response Gene 1 (Egr1) Fish Probe Kit For Specimen Characterization
Device class
Class 2
21 CFR
21 CFR 864.1870
Medical specialty
Hematology
Marketing pathway
510(K)
Flag
Third-party review eligible
510(k) clearances (all years, FDA)
1 (all years; only the last 3 years are listed here)

FDA classification definition

The EGR1 FISH Probe Kit for specimen characterization detects the LSI EGR1 probe target on chromosome 5q in bone marrow specimens. This assay is used to characterize bone marrow specimens from patients with acute myeloid leukemia (AML) or myelodysplastic syndrome. The assay results are to be interpreted by a qualified pathologist or cytogeneticist.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

Official FDA classification page: PDO
Classification and pathway per current FDA publications. Data from openFDA (CC0).